Who should attend?

The target audience of this event will be industry representatives interested in commercial development of early diagnostics, clinicians who can pitch an unmet clinical need, academics both at and out with the University working on technologies applicable to early diagnostics (including those not traditionally included in this space) and funding bodies.

We are particularly interested to include:

• Clinicians working in fields where early diagnosis is critical to patient outcomes, surgery and diagnostics.
• Academics working on key affiliated topics that are not otherwise represented at the University.
• Industry working in or seeking early diagnostic technologies, surgical guidance, ultrasound imaging, microfluidics, etc.

Benefits of attending

The need for earlier disease detection and diagnosis tools is already recognized at national and international policy levels and is reflected in a coordinated strategy of recent and upcoming funding calls. To be effective and competitive, strong interdisciplinary collaborative teams guided by clinical expertise with the flexibility to respond swiftly to emerging funding calls will be essential. Our aim is to establish such a consortium capable of making material contributions to this important field.